Anti-Aging Peptides: Building a Longevity Protocol That Makes Sense

Longevity peptides target four biological processes that decline measurably with age: cellular energy production, DNA and tissue repair signaling, circadian and sleep regulation, and collagen synthesis. A coherent protocol addresses these in the order that your laboratory results and symptoms indicate — not by stacking every compound available.

The problem with the longevity stack as it is usually sold

Search “longevity peptides” and you will find protocols listing eight or ten compounds taken simultaneously, presented as a package. This is backwards for three reasons. You cannot tell what is working. Interactions and cumulative burden go unassessed. And the cost is substantial for a protocol nobody has matched to your actual biology.

The approach that makes sense is sequential and measured: identify which aging processes are most advanced in you, address those, measure the response, and then decide what to add. That is how we build longevity protocols at Patients Medical, and it is why the workup comes before the prescription.

NAD+: cellular energy and repair

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme present in every cell, essential to converting food into usable energy and to the function of sirtuins and PARP enzymes involved in DNA repair and cellular maintenance. NAD+ levels decline substantially with age, and that decline is one of the more mechanistically well-supported contributors to reduced cellular resilience.

Patients receiving NAD+ therapy most commonly report improved energy, mental clarity, and recovery. It can be given intravenously — which we offer alongside our IV nutrient therapy — or subcutaneously, and it is frequently co-administered with peptides rather than used alone. Infusions are given slowly, because rapid administration produces a well-recognized flushing and chest-tightness sensation that resolves when the rate is reduced.

NAD+ is a foundation rather than a specialty item: patients whose energy production is compromised will get limited benefit from anything else until it is addressed. This overlaps heavily with stress-related depletion  and post-illness recovery.

Epitalon: circadian and pineal signaling

Epitalon is a synthetic peptide based on a substance isolated from the pineal gland. Research interest centers on its relationship to telomerase activity and telomere maintenance, and on its effect on melatonin and circadian rhythm.

The telomere research is genuinely interesting and genuinely preliminary — largely animal and cell studies, with long-term human outcome data absent. I am careful with patients here, because “telomere lengthening” is exactly the kind of claim that gets oversold. What patients more reliably report is the circadian effect: improved sleep timing and quality, particularly in those whose rhythm has been disrupted by shift work, chronic travel, or years of irregular schedules. Epitalon is typically given in short defined courses rather than continuously.

GHK-Cu: skin, hair, and collagen

GHK-Cu is a naturally occurring copper-binding tripeptide whose plasma concentration falls sharply with age. It has among the better-characterized mechanisms in this category: stimulating collagen and elastin synthesis, supporting wound healing, acting as an antioxidant, and influencing hair follicle activity.

It is used both topically — where it appears in cosmeceutical formulations for skin texture, fine lines, and firmness — and by injection for more systemic collagen and tissue support. For women in the years following menopause, when collagen decline accelerates sharply, it is one of the more visibly appreciated peptides; see peptides for women’s hormone balance. It is also used adjunctively for hair thinning.

Semax and Selank: cognitive longevity

Brain aging is the outcome most patients privately fear most, and cognitive complaints are among the most common reasons people seek longevity care.

Semax is associated with increased BDNF (brain-derived neurotrophic factor) expression, a key mediator of neuroplasticity and neuronal survival. Patients report improved focus, processing speed, and mental stamina; it is typically given intranasally.

Selank supports stress resilience and a calmer baseline without sedation, and the two are frequently paired — Semax providing sharpness, Selank preventing that sharpness from becoming agitation. Chronic stress is itself a driver of cognitive decline, which is why the calm side of the pairing is not cosmetic.

DSIP and sleep: the foundation nobody wants to hear about

Sleep is where longevity is either built or lost, and it is the intervention patients most want to skip in favor of something injectable.

Deep slow-wave sleep is when growth hormone is released, tissue is repaired, memory is consolidated, and — through the glymphatic system — metabolic waste is cleared from the brain. Chronic insufficient deep sleep is associated with essentially every outcome longevity medicine seeks to prevent.

DSIP supports sleep architecture rather than sedating, and evening-dosed growth hormone peptides deepen slow-wave sleep as part of their mechanism. Any longevity protocol that ignores sleep is not a longevity protocol.

Building a protocol in order

• Foundation first: Sleep, cellular energy (NAD+), and correction of anything found on the workup — thyroid, hormones, metabolic markers, nutrient deficiencies, inflammation. There is no point layering longevity peptides onto untreated hypothyroidism or an untreated sleep disorder.
• Then the targeted layer: Cognitive support, collagen and skin, circadian regulation, or tissue repair, chosen against your priorities and findings.
• Then measure: Repeat laboratory work, symptom tracking, and where appropriate biological age assessment. Add only after you know what the current layer did.

The laboratory workup

Comprehensive metabolic panel, HbA1c, fasting insulin, and full lipid panel including ApoB; hs-CRP and inflammatory markers; complete thyroid panel; full sex hormone panel; cortisol rhythm; IGF-1; vitamin D, B12, ferritin, homocysteine, and omega-3 index; and body composition. Advanced biological age and epigenetic testing may be added for patients who want a longitudinal benchmark.

Measuring whether it is working

Longevity medicine has a peculiar problem: the outcome you actually care about — more healthy years — cannot be measured on the timescale of a treatment decision. So we use proxies, and it is worth understanding which ones mean something.

• Metabolic markers are the most useful: Fasting insulin, HbA1c, ApoB, and triglyceride-to-HDL ratio track the processes most strongly linked to age-related disease. If a longevity protocol is not improving these, it is not doing much that matters.
• Inflammatory markers: hs-CRP and related markers reflect the chronic low-grade inflammation associated with essentially every age-related condition.
• Body composition: Muscle mass is among the strongest predictors of healthy aging and functional independence. Grip strength, easily measured, tracks with outcomes remarkably well.
• Sleep metrics: Deep sleep duration and consistency, whether from a wearable or a formal study, reflect the single most important recovery process.
• IGF-1: where growth hormone peptides are in use — targeted to a healthy range for age, not maximized.
• Biological age and epigenetic testing: offers a longitudinal benchmark that some patients find motivating. I present these results with appropriate caution: methodologies differ, results vary between tests, and the science is developing. They are useful for tracking your own trajectory over time, less useful as an absolute verdict.
• Functional benchmarks: How much you can lift, how far you can walk, how quickly you recover, how well you think at four in the afternoon. Patients frequently dismiss these as subjective; they are in fact closer to the outcome that matters than most laboratory values.

Ranking the evidence honestly

If I ordered longevity interventions by strength of evidence rather than by novelty, peptides would not be at the top — and any physician telling you otherwise is not being straight with you.

• Strongest evidence: not smoking, maintaining muscle mass through resistance training, cardiovascular fitness, sleep sufficiency and consistency, metabolic health, and social connection. These have decades of population-level data behind them and cost comparatively little.
• Strong evidence: treating identified conditions — hypertension, dyslipidemia, insulin resistance, thyroid disease, sleep apnea — and correcting nutrient deficiencies.
• Moderate and mechanistic evidence: hormone optimization where deficiency is confirmed, NAD+ support, GHK-Cu for collagen and tissue.
• Preliminary and promising: Epitalon’s telomere-related effects, several longevity peptide applications, and most of what is currently marketed most aggressively.

The reason to say this clearly is that patients frequently arrive wanting to purchase the fourth tier while the first tier remains unaddressed. The peptides will work considerably better — and cost considerably less over time — for a patient who has handled the foundation. That is not a reason to avoid peptides; it is the reason our workup looks the way it does. See also Are peptides safe? FDA rules and choosing a doctor .

Honest limitations

Longevity medicine attracts more claim than evidence, and patients deserve clarity about which is which. NAD+ decline and GHK-Cu’s mechanisms are relatively well characterized. Epitalon’s telomere effects are preliminary. Semax and Selank have decades of clinical use in some countries and limited Western trial data. No peptide has been shown in humans to extend lifespan — that study would take decades and has not been done.

What peptides can reasonably offer is support for the biological processes associated with healthy aging, alongside the interventions with the strongest evidence: resistance training, sleep, nutrition, muscle mass maintenance, metabolic health, and social connection. Peptides amplify a good foundation. They do not substitute for one, and any clinic implying otherwise should be treated cautiously. See Are peptides safe? FDA rules and choosing a doctor

Cost, commitment, and sequencing over time

Longevity protocols are the category where patients most often overspend, and a word about pacing is warranted.

Because these compounds are used over longer horizons than repair-focused peptides, the cumulative cost matters more than the monthly figure. A patient who starts four compounds simultaneously commits to a substantial ongoing expense while learning almost nothing about which of the four is responsible for any change.

The alternative I recommend is sequential: begin with the foundation and one targeted addition, run it for a defined period, measure, and only then decide what to add. This costs less, produces clearer information, and frequently ends with a simpler protocol than the patient expected to need — because the foundation work, once genuinely addressed, resolves more than anticipated.

Reassessment intervals are typically set at three to six months for this category, with laboratory work repeated at each point. Some compounds are cycled in defined courses rather than run continuously; others are used on maintenance schedules with periodic breaks. The structure is part of the prescription, not an afterthought, and it is reviewed at every follow-up rather than allowed to run indefinitely by default.

Peptide costs are additional to your consultation and vary with the type and amount prescribed, and follow-up visit fees depend on visit length and the treatment provided — so a protocol that is simpler is also less expensive to maintain and monitor, which is another argument for building it deliberately.

Frequently asked questions

Q. Do anti-aging peptides actually extend lifespan?

A. No human evidence demonstrates lifespan extension from any peptide. They support processes associated with healthy aging — a meaningful but narrower claim.

Q. Is NAD+ better as an IV or an injection?

A. IV produces higher immediate levels and is often used to start; subcutaneous is more practical for maintenance. Both are available at our Fifth Avenue office.

Q. How long do I stay on longevity peptides?

A. Varies by compound. Epitalon is typically cycled in defined courses; NAD+ and GHK-Cu are often used on longer maintenance schedules with periodic reassessment.

Q. Can I use GHK-Cu topically instead of injecting?

A. Yes for skin-focused goals. Injection is used where systemic tissue support is the aim.

Q. What is the single most valuable longevity intervention?

A. Not a peptide — it is sleep, followed by maintaining muscle mass. Peptides support both, which is precisely how they should be positioned.

Want a longevity protocol built on your labs rather than a package?

Learn about peptide therapy in NYC at Patients Medical, 1148 Fifth Avenue, Suite 1B, New York, NY 10128. Call (212) 794-8800 or start with a free 10-minute introductory call. Initial one-hour evaluation $600; peptide costs additional and vary by type and amount prescribed; follow-up fees depend on visit length and treatment provided.

Medical disclaimer: educational content only; not a substitute for professional medical advice, diagnosis, or treatment. Individual results vary; certain peptides are prescribed off-label or as compounded preparations.